Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer PR Newswire OSLO, Norway, Feb. 28, 2022 OSLO, Norway, Feb. 28...
Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway PR Newswire OSLO, Norway, Jan. 12, 2022 OSLO, Norway, Jan. 12, 2022...
Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma PR Newswire OSLO, Norway, Dec. 20, 2021 The...
Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma The median overall survival (mOS) was 25.0 months...
Targovax ASA: Third quarter 2021 results PR Newswire OSLO, Norway, Nov. 4, 2021 OSLO, Norway, Nov. 4, 2021 /PRNewswire/ -- Targovax ASA (OSE:...
Targovax: Presentation material for today's webcast PR Newswire OSLO, Norway, Oct. 25, 2021 OSLO, Norway, Oct. 25, 2021 /PRNewswire/ -- Targovax...
Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO PR Newswire OSLO, Norway, Oct. 20, 2021 OSLO, Norway, Oct. 20, 2021 /PRNewswire/...
Targovax to present at upcoming conferences PR Newswire OSLO, Norway, Oct. 19, 2021 OSLO, Norway, Oct. 19, 2021 /PRNewswire/ -- Targovax...
Targovax ASA: Two abstracts accepted at the SITC Congress PR Newswire OSLO, Norway, Oct. 6, 2021 OSLO, Norway, Oct. 6, 2021 /PRNewswire/...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.